Physical comorbidity, insight, quality of life and global functioning in first episode schizophrenia: A 24-month, longitudinal outcome study

Schizophrenia Research

Volumn 88, Issue 1-3, 2006, Pages 82-89

  Sim, Kang ^a   Chan, Yiong Huak ^b   Chua, Thiam Hee ^a   Mahendran, Rathi ^a   Chong, Siow Ann ^a   McGorry, Patrick ^c  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Comorbidity; First episode; Outcome; Physical; Schizophrenia

Indexed keywords

ADULT; ARTICLE; AWARENESS; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; COMORBIDITY; ENDOCRINE SYSTEM; FEMALE; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY SYSTEM; SCHIZOPHRENIA;

ADULT; COGNITION DISORDERS; COMORBIDITY; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; QUESTIONNAIRES; SCHIZOPHRENIA; TIME FACTORS;

EID: 33750607487     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.07.004     Document Type: Article

References (44)

1. Amador X.F., Flaum M., and Andreasen N.C. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch. Gen. Psychiatry 51 (1994) 826-836
2. Corcoran C., Walker E., Huot R., Mittal V., Tessner K., Kestler L., and Malaspina D. The stress cascade and schizophrenia: etiology and onset. Schizophr. Bull. 29 (2003) 671-692
3. Cournos F., Guido J.R., Coomaraswamy S., Meyer-Bahlburg H., Sugden R., and Horwath E. Sexual activity and risk of HIV infection among patients with schizophrenia. Am. J. Psychiatry 151 (1994) 228-232
4. Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J. Clin. Psychiatry 63 (2002) s5-s11
5. Davidson S., Judd F., Jolley D., Hocking B., Thompson S., and Hyland B. Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill. Aust. N. Z. J. Psychiatry 35 (2001) 203-209
6. Day J.C., Bentall R.P., Roberts C., Randall F., Rogers A., Cattell D., Healy D., Rae P., and Power C. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch. Gen. Psychiatry 62 (2005) 717-724
7. De Hert M., Hautekeete M., De Wilde D., and Peuskens J. High prevalence of Helicobacter pylori in institutionalized schizophrenic patients. Schizophr. Res. 26 (1997) 243-244
8. Dickerson F.B., Goldberg R.W., Brown C.H., Kreyenbuhl J.A., Wohlheiter K., Fang L., Medoff D., and Dixon L.B. Diabetes knowledge among persons with serious mental illness and type 2 diabetes. Psychosomatics 46 (2005) 418-424
9. Dixon L., Postrado L., Delahanty J., Fischer P.J., and Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. J. Nerv. Ment. Dis. 187 (1999) 496-502
10. Dixon L., Weiden P., Delahanty J., Goldberg R., Postrado L., Lucksted A., and Lehman A. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr. Bull. 26 (2000) 903-912
11. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM IV Axis I Disorders, Patient Edition (SCID-P), Version 2 (1994), New York State Psychiatric Institute, Biometrics Research, New York
12. Goh K.T. Prevention and control of hepatitis B virus infection in Singapore. Ann. Acad. Med. Singap. 26 (1997) 671-681
13. Goldman L.S. Medical illness in patients with schizophrenia. J. Clin. Psychiatry 60 Supp21 (1999) s10-s15
14. Gupta S., Masand P.S., Kaplan D., Bhandary A., and Hendricks S. The relationship between schizophrenia and irritable bowel syndrome (IBS). Schizophr. Res. 23 (1997) 265-268
15. Hall R.C., Gardner E.R., Popkin M.K., Lecann A.F., and Stickney S.K. Unrecognized physical illness prompting psychiatric admission: a prospective study. Am. J. Psychiatry 138 (1981) 629-635
16. Hasson-Ohayon I., Kravetz S., Roe D., David A.S., and Weiser M. Insight into psychosis and quality of life. Compr. Psychiatry 47 (2006) 265-269
17. Herrman H., Hawthorne G., and Thomas R. Quality of life assessment in people living with psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 37 (2002) 510-518
18. Hofer A., Kemmler G., Eder U., Edlinger M., Hummer M., and Fleischhacker W.W. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J. Clin. Psychiatry 65 (2004) 932-939
19. Joseph R., Ho L.Y., Gomez J.M., Rajdurai V.S., Sivasankaran S., and Yip Y.Y. Mass newborn screening for glucose-6-phosphate dehydrogenase deficiency in Singapore. Southeast Asian J. Trop. Med. Public Health 30 Suppl 2 (1999) 70-71
20. Josiassen R.C., and Schindler B. Medical comorbidity and schizophrenia: editors' introduction. Schizophr. Bull. 22 (1996) 411-412
21. Kamali M., Kelly B.D., Clarke M., Browne S., Gervin M., Kinsella A., Lane A., Larkin C., and O'Callaghan E. A prospective evaluation of adherence to medication in first episode schizophrenia. Eur. Psychiatr. 21 (2006) 29-33
22. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13 (1987) 261-276
23. Kendrick T. Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness. Br. J. Psychiatry 169 (1996) 733-739
24. Koran L.M., Sox Jr. H.C., Marton K.I., Moltzen S., Sox C.H., Kraemer H.C., Imai K., Kelsey T.G., Rose Jr. T.G., and Levin L.C. Medical evaluation of psychiatric patients. I. Results in a state mental health system. Arch. Gen. Psychiatry 46 (1989) 733-740
25. Koranyi E.K. Morbidity and rate of undiagnosed physical illnesses in a psychiatric clinic population. Arch. Gen. Psychiatry 36 (1979) 414-419
26. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., and Weissman M.M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch. Gen. Psychiatry 39 (1982) 879-883
27. Lobban F., Barrowclough C., and Jones S. The impact of beliefs about mental health problems and coping on outcome in schizophrenia. Psychol. Med. 34 (2004) 1165-1176
28. Lyketsos C.G., Dunn G., Kaminsky M.J., and Breakey W.R. Medical comorbidity in psychiatric inpatients: relation to clinical outcomes and hospital length of stay. Psychosomatics 43 (2002) 24-30
29. Meltzer H.Y., Davidson M., Glassman A.H., and Vieweg W.V. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. J. Clin. Psychiatry 63 Suppl 9 (2002) 25-29
30. Ministry of Health. National Health Surveillance Survey 2001 (2001), Epidemiology and Disease Control Division, Singapore 38-41
31. Nasrallah H.A. Factors in antipsychotic drug selection: tolerability considerations. CNS Spectr. 8 (2003) 23-25
32. Ng T.P. Adult asthma prevalence, morbidity and mortality and their relationships with environmental and medical care factors in Singapore. Asian Pac. J. Allergy Immunol. 17 (1999) 127-135
33. Saxena S., Carlson D., and Billington R. The WHO quality of life assessment instrument (WHOQOL-Bref): the importance of its items for cross-cultural research. Qual. Life Res. 10 (2001) 711-721
34. Schwartz R.C., Cohen B.N., and Grubaugh A. Does insight affect long-term impatient treatment outcome in chronic schizophrenia?. Compr. Psychiatry 38 (1997) 283-288
35. Sernyak M.J., Leslie D.L., Alarcon R.D., Losonczy M.F., and Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am. J. Psychiatry 159 (2002) 561-566
36. Sokal J., Messias E., Dickerson F.B., Kreyenbuhl J., Brown C.H., Goldberg R.W., and Dixon L.B. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J. Nerv. Ment. Dis. 192 (2004) 421-427
37. Stefan M.D., and Catalan J. Psychiatric patients and HIV infection: a new population at risk?. Br. J. Psychiatry 167 (1995) 721-727
38. Strakowski S.M., Keck Jr. P.E., McElroy S.L., Lonczak H.S., and West S.A. Chronology of comorbid and principal syndromes in first-episode psychosis. Compr. Psychiatry 36 (1995) 106-112
39. Tan K.H., Tan T.Y., Tan J., Tan I., Chew S.K., and Yeo G.S. Birth defects in Singapore: 1994-2000. Singap. Med. J. 46 (2005) 545-552
40. Tay Y.K., Khoo B.P., and Goh C.L. The epidemiology of atopic dermatitis at a tertiary referral skin center in Singapore. Asian Pac. J. Allergy Immunol. 17 (1999) 137-141
41. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol. Med. 28 (1998) 551-558
42. Ucok A., Polat A., Cakir S., and Genc A. One year outcome in first episode schizophrenia. Predictors of relapse. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006) 37-43
43. Wong T.Y., Tielsch J.M., and Schein O.D. Racial difference in the incidence of retinal detachment in Singapore. Arch. Ophthalmol. 117 (1999) 379-383
44. Yao G., Chung C.W., Yu C.F., and Wang J.D. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J. Formos. Med. Assoc. 101 (2002) 342-351